Key companies like Novartis, Curium Pharma, Lantheus, Eli Lilly and Company, Fusion Pharmaceuticals, AstraZeneca, Clarity Pharmaceuticals, Bayer, ITM Isotope Technologies, ARTBIO, Convergent Therapeutics, Perspective Therapeutics, PRECIRIX, Ariceum Therapeutics, Nuclidium, and
Radioligand Therapy Market is Expected to Grow Rapidly by 2036, Estimates DelveInsight
The market dynamics for Chronic Myeloid Leukemia (CML) are witnessing substantial growth driven by the increasing incidence of CML, growing adoption of targeted therapies, rising awareness regarding molecular diagnostics, and
The market dynamics for Sjogren’s Syndrome are witnessing steady growth driven by the increasing prevalence of autoimmune disorders, rising awareness regarding early diagnosis, growing burden of chronic dry eye and
The market dynamics for Acute on Chronic Liver Failure (ACLF) are witnessing steady growth driven by the rising prevalence of chronic liver diseases, increasing burden of alcohol-related liver disorders and
American Lithium Minerals, Inc. (OTC: AMLM) continues advancing its strategy to build shareholder value across a diversified portfolio of critical
As global markets accelerate toward electrification, energy efficiency, and next-generation materials, Graphene Manufacturing Group Ltd (TSXV: GMG) (OTCQX: GMGMF)
As the global healthcare system rapidly scales to treat metabolic dysfunction–associated steatotic liver disease (MASLD) and expand GLP-1 therapies, ENDRA
A growing group of sub-$1 “Mag Microcaps” is capturing investor attention as volume surges align with major catalysts across
1606 Corp. (OTC: CBDW) continues advancing its strategy to build an AI-focused energy and data infrastructure platform, announcing progress toward
Low Foam Surfactants Market Asia-Pacific leads the Low Foam Surfactants Market with around 42% share, underpinned by large-scale agrochemical and
